RxDoctor Payments Data

Wyatt Blake, MD

Family Medicine · Gray, GANPI 1548263064

Payments from drug & device makers

$369in general payments, 2019–2025

Across 17 payments — averaging $21.73 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Lilly USA, LLC$147
  • Johnson & Johnson$50
  • Sunovion Pharmaceuticals Inc.$48
  • Sumitomo Pharma America, Inc.$44
  • Teva Pharmaceuticals USA, Inc.$27
  • Pfizer$22
  • plus $32 from 2 others

What the payments were for

  • Food & beverage$369100%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

19
20
22
23
24

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

How this compares

$369 in reported general payments places this provider in the 40th percentile of 3,111 family medicine providers in Georgia.

See all family medicine providers in Georgia

Medicare billing

Part B allowed, 2024
$191,410
Medicare patients
643
Services billed
1,866

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
EliquisApixaban5,172$773,166
TrulicityDulaglutide500$254,651
XareltoRivaroxaban867$130,361
JardianceEmpagliflozin814$121,195
Trelegy ElliptaFluticasone/Umeclidin/Vilanter145$100,577
Rosuvastatin Calcium11,846$82,786
JanuviaSitagliptin Phosphate526$81,547
LinzessLinaclotide133$76,244
RexultiBrexpiprazole171$70,255
OzempicSemaglutide48$48,838
Omeprazole8,198$48,814
Levothyroxine Sodium7,088$45,050
MyrbetriqMirabegron382$44,183
Gabapentin6,577$43,597
EntrestoSacubitril/Valsartan260$43,199

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
PfizerEliquis$22$773,1665,172 claims
Lilly USA, LLCTrulicity$147$254,651500 claims
Johnson & JohnsonXarelto$50$130,361867 claims
Sumitomo Pharma America, Inc.Gemtesa$44$31,964264 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 40th percentile of 3,111 family medicine providers in Georgia.

Other family medicine in Gray

See the full list for Georgia

Where these figures come from

Is this you, or does something look wrong? →